HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
US Application 19/376,412
Filed on 2025-10-31
Filed on 2025-10-31
RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES
South Korea
10-2025-7029082
Filed on 2025-09-01
10-2025-7029082
Filed on 2025-09-01
Prefusion RSV F Proteins And Their Use
Canada
3291895
Filed on 2025-11-11
3291895
Filed on 2025-11-11
HIV-1 ENVELOPE TRIPLE TANDEM TRIMERS AND THEIR USE
US Application 19/488,691
Filed on 2025-11-28
Filed on 2025-11-28
SARS-CoV-2 VACCINE
Israel
324082
Filed on 2025-10-20
324082
Filed on 2025-10-20
RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN
US Application 19/484,594
Filed on 2025-11-14
Filed on 2025-11-14
Nanoparticle-based Influenza Virus Vaccines and Uses Thereof
Australia
2025230782
Filed on 2025-09-12
2025230782
Filed on 2025-09-12
ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT BIND TO MONKEYPOX VIRUSPROTEIN A35 AND VACCINIA VIRUS PROTEIN A33 AND METHODS OF USE
US Application 63/723,296
Filed on 2024-11-21
Filed on 2024-11-21
MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE
US Application 19/352,878
Filed on 2025-10-08
Filed on 2025-10-08